CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 8-K Event Other events
- 4 Open-market buy President and CEO bought 14,288 shares at $5.91 ($84,465)
- 4 Open-market buy Director bought 1,700 shares at $5.85 ($9,945)
- 4/A Open-market buy President and CEO bought 21,547 shares at an average $5.91 ($127,449)
- 4 Open-market buy Director bought 5,000 shares at $6.00 ($30,000)
- 4 Open-market buy President and CEO bought 13,000 shares at an average $5.85 ($75,990)
- 4 Open-market buy Director bought 1,700 shares at $5.86 ($9,964)
- 4 Open-market buy Director bought 20,000 shares at an average $5.89 ($117,805)
- 4 Open-market buy President and CEO bought 20,000 shares at an average $5.14 ($102,824)
- 4 Open-market buy Director bought 20,000 shares at an average $5.00 ($99,963)
- 4 Open-market buy Chief Medical Officer bought 5,000 shares at $5.06 ($25,311)
- 4 Open-market buy Chief Financial Officer bought 3,200 shares at $4.71 ($15,072)
- 4 Open-market buy Chief Commerical Officer bought 4,329 shares at $4.68 ($20,260)
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 17 of 33 · 650 filings